Skip to content
Search AI Powered

Latest Stories

New Study Confirms Just How Ineffective Ivermectin Is at Treating the Virus and the Mockery of Trump Was Swift

New Study Confirms Just How Ineffective Ivermectin Is at Treating the Virus and the Mockery of Trump Was Swift
James Devaney/GC Images

When they weren't downplaying the COVID-19 virus that's gone on to kill nearly one million Americans, conservatives across the country were baselessly promoting phony "cures" for those who contracted it.

Former President Donald Trump was one of the worst offenders. He regularly touted the malaria drug hydroxychloroquine and the anti-parasitic drug ivermectin, which is used in humans to treat conditions like roundworm and rosacea. Ivermectin is also the active ingredient in a number of animal deworming treatments.


Trump's fixation on ivermectin trickled down to his supporters, many of whom accused doctors of withholding the supposed cure out of greed. Right-wing Senator Rand Paul of Kentucky said at a town hall event last year that the medical industry's "hatred" for Trump made them "unwilling to objectively study" ivermectin.

But contrary to Paul's claims, studies have been done on ivermectin's effectiveness in treating COVID-19, and the results of one large-scale study had some less-than-ideal findings for those insisting ivermectin is a miracle drug.

A recent report from the New York Times revealed that a large scale clinical trial of the drug showed no effectiveness in reducing COVID-19 hospitalization.

The study, published this past Wednesday, used more than 3500 patients, 679 of whom were treated with ivermectin, 679 with a placebo, and 2157 with other treatments.

The report states:

"Treatment with ivermectin did not result in a lower incidence of medical admission to a hospital due to progression of Covid-19 or of prolonged emergency department observation among outpatients with an early diagnosis of Covid-19."

What's more, doctors fear that the emphasis on ivermectin and the resources deployed to explore its effectiveness are hemorrhaging resources.

Dr. Paul Sax, an infectious disease expert who did not work on the trial, told the New York Times:

“I welcome the results of the other clinical trials and will view them with an open mind, but at some point it will become a waste of resources to continue studying an unpromising approach."

The report generated widespread discussion on social media, with many calling out the former President and his supporters for baselessly touting its supposed effectiveness.






Few were surprised.



Awkward.

More from News/science

dog and cat snuggling together
Krista Mangulsone on Unsplash

Times Pet Owners 'Severely Underestimated' Their Pets' Intelligence

I've lived with cats—because no one owns a feline—most of my life. Some have been very clever creatures while others were real dingbats.

Family members have owned dogs whose talents also ran the gamut.

Keep ReadingShow less
Scott Bessent
Meet the Press/NBC News

Scott Bessent Blasted Over His Bonkers Suggestion For How To Bring Your Own Inflation Rate Down

Continuing to follow the example of MAGA Republican President Donald Trump, Treasury Secretary Scott Bessent appeared on Meet the Press Sunday to blame Democratic President Joe Biden for the financial downturn caused by Trump's tariff fiasco, then lied repeatedly about the state of the economy.

Meet the Press host Kristen Welker played a clip of MAGA Republican Vice President JD Vance telling a conservative audience at a Breitbart News event that Americans owe the Trump administration "a little bit of patience"—apparently while they figure out what tariffs are and how they work since they're rolling back more of them to lower consumer prices despite claiming Trump's tariffs don't affect consumer prices.

Keep ReadingShow less
Lindsay Lohan attends the men's final during day fifteen of the 2025 US Open Tennis Championships at USTA Billie Jean King National Tennis Center.
Elsa/Getty Images

Lindsay Lohan Is Now Sporting A New Accent—And Fans Aren't Sure What To Make Of It

In a twist freakier than a sequel to Freaky Friday, Lindsay Lohan has debuted yet another new accent—this time at the Fashion Trust Arabia Awards in Doha, Qatar.

Draped in a maroon, jewel-trimmed gown by The New Arrivals Ilkyaz Ozel and accompanied by her husband, Bader Shammas, and their 2-year-old son, Luai, the actress looked serene, elegant, and completely unbothered by the collective whiplash she was about to inflict on the internet.

Keep ReadingShow less
Jameela Jamil
Gilbert Flores/Variety/Getty Images

Jameela Jamil Speaks Out Against The Rise Of The 'Aesthetic Of Emaciation' Among Women In Hollywood

Content Warning: eating disorders, thinness as an aesthetic, emaciation in Hollywood

There's no denying that we've been gifted with some incredible music, television shows, and films this year.

Keep ReadingShow less
Donald Trump; Screenshot of Jackie Chan and Chris Tucker in "Rush Hour 2"
Andrew Caballero-Reynolds/AFP via Getty Images; New Line Cinema

Trump Is Now Using His Presidential Sway To Pressure Studio Into Making 'Rush Hour 4'—And, Huh?

President Trump has reportedly pressured Paramount head Larry Ellison to make another sequel to Rush Hour, his favorite buddy-cop movie, as the company looks to acquire Warner Bros. Discovery.

The first Rush Hour film, starring Jackie Chan and Chris Tucker, was released in 1998, received positive reviews, and made $245 million worldwide. Chan and Tucker returned for two sequels released in 2001 and 2007 respectively.

Keep ReadingShow less